-
AI Process Discovers, Tests Fibrosis Drug in 18 Months
A provider of drug discovery services based on artificial intelligence says in 18 months it identified and tested in mice a new drug for a chronic lung disease.
-
Synthetic RNA Start-Up Gains $80M in Early Funds
A start-up company, spun off from a biomedical engineering lab at MIT, is raising $80 million for therapies made from synthetic circular RNA.
-
Gene-Editing Biotech Acquires DNA Bar Code Company
A developer of therapies using highly precise gene editing is acquiring a company delivering gene therapies identified with DNA bar codes.
-
What Happens When Property is Sold in Malaysia?
There are things to understand about Malaysia’s property market, mainly relating to taxes and selling your properties.
-
ALS Trial Results Deemed Insufficient for FDA Approval
An ALS treatment developer says the Food and Drug Administration advised the company’s clinical trial data would likely not support approval for patient use.
-
FDA Issues Covid-19 Variant Regulatory Guidance
Food and Drug Administration is updating its regulatory guidance for Covid-19 drugs and diagnostics to cover emerging mutations in the SARS-CoV-2 virus.
-
New Trial Testing Reformulated Covid-19 Vaccine
Two drug makers are beginning a clinical trial to test their reformulated vaccine against Covid-19 disease, particularly among older populations.
-
Infographic – Top Venture Investor in Each State
CB Insights compiled a list of the top technology venture investors in each state and D.C., and displayed the investors on a map.
-
Novavax Providing 1.1B Vaccine Doses to Global Group
Novavax, developer of a vaccine to prevent Covid-19 disease, is providing 1.1 billion doses of its vaccine for distribution to lower resource regions.
-
Crispr-Edited Bananas Get Industry Funding
A popular type of banana, genetically edited to resist a soil fungus that threatens this fruit worldwide, is now backed by a major American food brand.